Table 2.
Component of immune response | Potential effects of RT | Potential effects of chemotherapy |
---|---|---|
Antigen presentation | Translocation of calreticulin to cell surface activates dendritic and other antigen presenting cells7,106 Enhanced MHC class I expression30 Release of danger-associated molecular patterns (DAMPs) recruits and stimulates dendritic cells. 29 |
Increased antigen cross-presentation and dendritic cell activation107 Induction of immunogenic cell death44 |
T-cell response, trafficking | Results in systemic inflammatory repsonse39 Release of alarmin and binding to TLR4 activates antitumor immunity108 CXCL16 release attracts effector T cells109 Tumor vascular endothelial changes promote immune cell extravasation8,110 |
Release of alarmin and binding to TLR4 activates antitumor immunity108 Increased intratumoral T cell accumulation111,112 |
Target destruction | Tumor debulking | Tumor debulking |
Generation of memory | Unknown | Increasing memory against tumor antigen47 |
MHC, major histocompatibility complex; TLR, toll-like receptor